Johnson PJ - Search Results

1

Phase II studies with DaunoXome in patients with nonresectable hepatocellular carcinoma: clinical and pharmacokinetic outcomes.

Yeo W, Chan KK, Mukwaya G, Ross M, Leung WT, Ho S, Chan AT, Johnson PJ. Yeo W, et al. Among authors: johnson pj. Cancer Chemother Pharmacol. 1999;44(2):124-30. doi: 10.1007/s002800050956. Cancer Chemother Pharmacol. 1999. PMID: 10412946 Clinical Trial.

2

Hepatocellular carcinoma during pregnancy and its comparison with other pregnancy-associated malignancies.

Lau WY, Leung WT, Ho S, Lam SK, Li CY, Johnson PJ, Williams R, Li AK. Lau WY, et al. Among authors: johnson pj. Cancer. 1995 Jun 1;75(11):2669-76. doi: 10.1002/1097-0142(19950601)75:11<2669::aid-cncr2820751105>3.0.co;2-b. Cancer. 1995. PMID: 7743468 Review.

3

Isoelectric focusing of alphafetoprotein in patients with hepatocellular carcinoma--frequency of specific banding patterns at non-diagnostic serum levels.

Ho S, Cheng P, Yuen J, Chan A, Leung N, Yeo W, Leung T, Lau WY, Li AK, Johnson PJ. Ho S, et al. Among authors: johnson pj. Br J Cancer. 1996 Apr;73(8):985-8. doi: 10.1038/bjc.1996.192. Br J Cancer. 1996. PMID: 8611436 Free PMC article.

4

Phase II study of the combination of carboplatin and 5-fluorouracil in metastatic nasopharyngeal carcinoma.

Yeo W, Leung TW, Leung SF, Teo PM, Chan AT, Lee WY, Johnson PJ. Yeo W, et al. Among authors: johnson pj. Cancer Chemother Pharmacol. 1996;38(5):466-70. doi: 10.1007/s002800050512. Cancer Chemother Pharmacol. 1996. PMID: 8765441 Clinical Trial.

5

The role of chemotherapy in the management of nasopharyngeal carcinoma.

Chan AT, Teo PM, Leung TW, Johnson PJ. Chan AT, et al. Among authors: johnson pj. Cancer. 1998 Mar 15;82(6):1003-12. doi: 10.1002/(sici)1097-0142(19980315)82:6<1003::aid-cncr1>3.0.co;2-f. Cancer. 1998. PMID: 9506343 Review.

6

Phase II study of Temodal in the treatment of patients with advanced nasopharyngeal carcinoma.

Chan AT, Leung TW, Kwan WH, Mok TS, Yeo W, Lai M, Johnson PJ. Chan AT, et al. Among authors: johnson pj. Cancer Chemother Pharmacol. 1998;42(3):247-9. doi: 10.1007/s002800050812. Cancer Chemother Pharmacol. 1998. PMID: 9685061 Clinical Trial.

7

A phase II study of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma.

Yeo W, Leung TW, Chan AT, Chiu SK, Yu P, Mok TS, Johnson PJ. Yeo W, et al. Among authors: johnson pj. Eur J Cancer. 1998 Dec;34(13):2027-31. doi: 10.1016/s0959-8049(98)00280-9. Eur J Cancer. 1998. PMID: 10070305 Clinical Trial.

8

Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma.

Leung TW, Patt YZ, Lau WY, Ho SK, Yu SC, Chan AT, Mok TS, Yeo W, Liew CT, Leung NW, Tang AM, Johnson PJ. Leung TW, et al. Among authors: johnson pj. Clin Cancer Res. 1999 Jul;5(7):1676-81. Clin Cancer Res. 1999. PMID: 10430068 Clinical Trial.

9

Combating hepatocellular carcinoma with an integrated approach.

Ho S, Johnson PJ, Leung WT, Lau WY. Ho S, et al. Among authors: johnson pj. Chin Med J (Engl). 1999 Jan;112(1):80-3. Chin Med J (Engl). 1999. PMID: 11593648

10

Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy.

Yeo W, Lam KC, Zee B, Chan PS, Mo FK, Ho WM, Wong WL, Leung TW, Chan AT, Ma B, Mok TS, Johnson PJ. Yeo W, et al. Among authors: johnson pj. Ann Oncol. 2004 Nov;15(11):1661-6. doi: 10.1093/annonc/mdh430. Ann Oncol. 2004. PMID: 15520068 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

962 results

Search Page

Filters